Novartis India Ltd has announced an upcoming investor and analyst meeting to engage with institutional stakeholders.

The interaction will be held in a hybrid format, allowing both virtual and physical participation from Mumbai.

Management has clarified that discussions will strictly rely on publicly available information, ensuring no unpublished price-sensitive data is shared.

For retail shareholders, this engagement offers insight into the company's communication strategy with institutional investors, while associated presentation materials will be publicly accessible prior to the event on the official website and stock exchange.